• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微生物产生的低分子量免疫调节剂。

Low molecular weight immunomodulators produced by microorganisms.

作者信息

Ishizuka M, Kawatsu M, Yamashita T, Ueno M, Takeuchi T

机构信息

Institute for Chemotherapy, Microbial Chemistry Research Foundation, Shizuoka, Japan.

出版信息

Int J Immunopharmacol. 1995 Feb;17(2):133-39. doi: 10.1016/0192-0561(94)00086-4.

DOI:10.1016/0192-0561(94)00086-4
PMID:7657405
Abstract

In order to develop a new class of low molecular weight immunomodulators for the treatment of incurable diseases involving cancer, hematologic diseases and inflammation, we have sought cytokine inducers and inhibitors of cell adhesion to the extracellular matrix among the low molecular compounds produced by microorganisms. Cytogenin, cytoblastin (a monokine inducer), conagenin (a lymphokine inducer) and delaminomycins and IC-101 (inhibitors of cell adhesion to extracellular matrices) have been recently found in our institute. In this report, we describe the principles of screening and structures, and discuss their biological activities.

摘要

为开发一类新型低分子量免疫调节剂用于治疗包括癌症、血液系统疾病和炎症在内的不治之症,我们在微生物产生的低分子化合物中寻找细胞因子诱导剂和细胞与细胞外基质粘附的抑制剂。细胞生成素、成细胞素(一种单核因子诱导剂)、促胶原蛋白(一种淋巴因子诱导剂)以及脱层霉素和IC-101(细胞与细胞外基质粘附的抑制剂)最近已在我们研究所被发现。在本报告中,我们描述了筛选原理和结构,并讨论了它们的生物学活性。

相似文献

1
Low molecular weight immunomodulators produced by microorganisms.微生物产生的低分子量免疫调节剂。
Int J Immunopharmacol. 1995 Feb;17(2):133-39. doi: 10.1016/0192-0561(94)00086-4.
2
Delaminomycins, novel extracellular matrix receptor antagonist. IV. Structure-activity relationships of delaminomycins and derivatives.
J Antibiot (Tokyo). 1993 Jul;46(7):1156-62. doi: 10.7164/antibiotics.46.1156.
3
Delaminomycins, novel nonpeptide extracellular matrix receptor antagonist and a new class of potent immunomodulator. II. Physico-chemical properties and structure elucidation of delaminomycin A.
J Antibiot (Tokyo). 1993 Jun;46(6):979-84. doi: 10.7164/antibiotics.46.979.
4
Conagenin, a low molecular weight immunomodulator produced by Streptomyces roseosporus.玫瑰孢链霉菌产生的一种低分子量免疫调节剂——可那吉宁。
J Antibiot (Tokyo). 1991 May;44(5):557-9. doi: 10.7164/antibiotics.44.557.
5
Delaminomycins, novel extracellular matrix receptor antagonist. III. Physico-chemical properties and structure elucidation of delaminomycins B and C.
J Antibiot (Tokyo). 1993 Jun;46(6):1020-3. doi: 10.7164/antibiotics.46.1020.
6
Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.建立多卡霉素和CC-1065烷基化亚基的衍生物及类似物的反应性与活性之间的抛物线关系。
J Am Chem Soc. 2004 Jan 14;126(1):80-1. doi: 10.1021/ja038162t.
7
T cell activation by conagenin in mice.小鼠中伴刀豆球蛋白对T细胞的激活作用。
J Antibiot (Tokyo). 1993 Nov;46(11):1687-91. doi: 10.7164/antibiotics.46.1687.
8
[Low molecular weight immunomodulators produced by microorganisms].[微生物产生的低分子量免疫调节剂]
Gan To Kagaku Ryoho. 1984 Dec;11(12 Pt 2):2709-14.
9
Synthesis and antitumor activity of duocarmycin derivatives: A-ring pyrrole compounds bearing cinnamoyl groups.柔红霉素衍生物的合成及其抗肿瘤活性:带有肉桂酰基的A环吡咯化合物。
J Med Chem. 1997 Mar 14;40(6):972-9. doi: 10.1021/jm9606094.
10
Cytotoxic tetramic acid derivative produced by a plant type-III polyketide synthase.植物型 III 聚酮合酶产生的细胞毒性四氢酸衍生物。
J Am Chem Soc. 2011 Apr 6;133(13):4746-9. doi: 10.1021/ja2006737. Epub 2011 Mar 10.

引用本文的文献

1
Challenges and limitations in using bacterial metabolites as immunomodulators.将细菌代谢产物用作免疫调节剂的挑战与局限
Front Cell Infect Microbiol. 2025 Jan 29;15:1535394. doi: 10.3389/fcimb.2025.1535394. eCollection 2025.
2
immunomodulatory potential of Willd. in chicken lymphocytes.Willd.对鸡淋巴细胞的免疫调节潜力。
Vet World. 2018 Jan;11(1):80-87. doi: 10.14202/vetworld.2018.80-87. Epub 2018 Jan 28.